SPRB chart
Full chart
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Key stats
Market capitalization
19.98 MUSD
—
—
−1.1451USD
−47.92 MUSD
10.09 MUSD
28.37 M
Beta (1Y)
2.43
About Spruce Biosciences, Inc.
Sector
Industry
CEO
Javier Szwarcberg
Website
Headquarters
South San Francisco
Employees (FY)
29
Founded
2014
FIGI
BBG00HYZ1522
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
Financials
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
Ideas
RiskMastery's Breakout Stocks - SPRB EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential. In this edition, we'll be looking at NASDAQ:SPRB ...I believe this code is at a point of potential volatility. If price can hold above $3.40 ... Bullish potential may be unlocked.My key upside targets include
Long
SPRB SPRB Minimum time of 15 days and a maximum of 2 months you will see a movement from these levels between 40-100% up or beyondthe Setting has been studied with a risk-return accuracy of 80%
Long
33
SPRBSpruce Biosciences Inc (NASDAQ:SPRB) This small bio cap had a very productive day on Friday as we saw gains of over 100% and based on the technical daily chart I believe it has more room to run. The stock finds an immediate resistance at 5.80 and support at 4.25 followed by 3.89 (EMA50). This stock
Long
SPRB ReversalThis was brought to my attention by a friend on Stocktwits. It has sold off tremendously in recent months and made an all time low a few days ago at $4.23.Since then the MACD has crossed and the price has moved up gradually. The RSI is still very oversold at 38. Also I would like to see a daily
Long
SPRB - 7.7M FLOAT - JUST BUY IT All,Lets look at just RSI along on the WEEKLY. Yes it is below 5. Yes this company has 3 years of cash flow. Yes the avg PT is $30. Yes it's 7.7M float. Yes when news / ER comes out this will moon.Question is when? Answer I don't care anymore. I'm in... 2 years or 2 days. Do your DD but trust me
Long
SPRB - 8M FLOAT - WORTH X2-X3 CURRENT PRICEAll,I am already scaled in big here. I am without a doubt this stock will at least double. ***KEEP IN MIND THIS IS AN 8M FLOAT COMPANY1. Do your own DD you will notice all that has really happened is low float short sellers have just railed the price down2. This companies price targets are in
Long
$SPRB- press release comingPress release coming 19-25th. Also hit important volume shelf yesterday. Planning on playing the anticipation here, sell on Friday.
Long
Spruce Ready for breakoutOn support and ready for a move to the upside.
Long
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of
SPRB
is
0.4682
USD
— it has increased by
2.18
% in the past 24 hours. Watch
Spruce Biosciences, Inc.
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
Spruce Biosciences, Inc.
stocks are traded under the ticker
SPRB
.
SPRB
stock has fallen by
−10.99
% compared to the previous week, the month change is a
−16.85
% fall, over the last year
Spruce Biosciences, Inc.
has showed a
−79.95
% decrease.
We've gathered analysts' opinions on
Spruce Biosciences, Inc.
future price: according to them,
SPRB
price has a max estimate of
3.00
USD
and a min estimate of
2.00
USD
. Watch
SPRB chartand read a more detailed
Spruce Biosciences, Inc. stock forecast: see what analysts think of
Spruce Biosciences, Inc.
and suggest that you do with its stocks.
SPRB
reached its all-time high on
Nov 27, 2020
with the price of
35.6000
USD
, and its all-time low was
0.5030
USD
and was reached on
Jun 21, 2024
. View more price dynamics on
SPRB chart.
See other stocks reaching their highest and lowest prices.
SPRB
stock is
4.59
% volatile and has beta coefficient of
2.43
. Track
Spruce Biosciences, Inc.
stock price on the chart and check out the list of the most volatile stocks — is
Spruce Biosciences, Inc.
there?
Today
Spruce Biosciences, Inc.
has the market capitalization of
18.86 M
, it has increased by
3.75
% over the last week.
Yes, you can track
Spruce Biosciences, Inc. financialsin yearly and quarterly reports right on TradingView.
Spruce Biosciences, Inc.
is going to release the next earnings report on
Aug 7, 2024
. Keep track of upcoming events with our Earnings Calendar.
SPRB
earnings for the last quarter are
−0.28
USD
per share, whereas the estimation was
−0.29
USD
resulting in a
2.97
% surprise. The estimated earnings for the next quarter are
−0.32
USD
per share. See more details about
Spruce Biosciences, Inc. earnings.
for the last quarter amounts to
2.00 M
USD
, despite the estimated figure of
1.15 M
USD
. In the next quarter, revenue is expected to reach
1.50 M
USD
.
SPRB
net income for the last quarter is
−11.63 M
USD
, while the quarter before that showed
−9.95 M
USD
of net income which accounts for
−16.83
% change. Track more
Spruce Biosciences, Inc. financial statsto get the full picture.
No,
SPRB
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Aug 7, 2024
, the company has
29.00
employees. See our rating of the largest employees — is
Spruce Biosciences, Inc.
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
Spruce Biosciences, Inc.
EBITDA is
−51.30 M
USD
, and current EBITDA margin is
−514.65
%. See more stats in
Spruce Biosciences, Inc. financial statements.
Like other stocks,
SPRB
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
Spruce Biosciences, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
Spruce Biosciences, Inc.
technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
Spruce Biosciences, Inc.
stock shows the sell signal. See more of
Spruce Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
